Pfizer Drops $119 Billion Bid For AstraZeneca

Pharmaceutical giant Pfizer has been circling its smaller rival for months. AstraZeneca has rejected every offer saying Pfizer undervalues the company, and that it wants to remain independent.

» E-Mail This

from News http://ift.tt/1tgGoDB

via Richard Aquilone

from WordPress http://ift.tt/1tgL7VP

via IFTTT